Back to search

National and Kapodistrian University of Athens

Μια μονοκεντρική, φάσης ΙΙ, τυφλοποιημένη ως προς τον αξιολογητή, τυχαιοποιημένη, ελεγχόμενη με ενεργό θεραπεία, παράλληλων ομάδων κλινική μελέτη για τη σύγκριση της τικαγκρελόρης έναντι της κλοπιδογρέλης στη μείωση της αορτικής σκληρίας και της ανάκλασης των κυμάτων πίεσης σε ασθενείς με στεφανιαία νόσο: η μελέτη “NOVELTY”

Abstract

dc:description

Background: We compared the acute and midterm effect of ticagrelor versus clopidogrel on aortic stiffness. Methods and Results: We studied 117 patients in a randomized, assessor-blinded, parallel-group trial. The acute effect of ticagrelor was studied in 58 patients randomized (1:1) to receive a loading dose of clopidogrel (600 mg) or ticagrelor (180 mg). Carotid-femoral pulse wave velocity (cfPWV) was measured before, 3, and 24 hours after the loading dose. The midterm effect (30-day treatment period) was studied in 59 subjects who underwent percutaneous coronary intervention and were randomized to either clopidogrel (75 mg, OD) or ticagrelor (90 mg BID). cfPWV was measured before and at 30 days of treatment. Circulating markers of inflammation and endothelial function were measured at all study points. Repeated-measures analysis showed a significant main effect for treatment (P=0.03), with the ticagrelor showing a reduction in cfPWV after treatment. cfPWV at 24 hours was significantly lower in the ticagrelor group compared with the clopidogrel group (P=0.017) (maximal response reduction by 0.420.26 m/s). At 30 days, cfPWV decreased in the ticagrelor group, whereas there was no change with clopidogrel (-0.43 ± 0.57 versus 0.12 ± 0.14 m/s, P=0.004). There were no significant changes in both the acute and midterm study period in the pro-inflammatory and endothelial function parameters. Conclusions: Ticagrelor decreases cfPWV for 24 hours after the loading dose and at 1 month post–percutaneous coronary intervention compared with clopidogrel. Considering that aortic stiffness is an independent predictor of cardiovascular events, this finding may have clinical implications regarding the beneficial effect of ticagrelor.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Georgakopoulos, Christos
  • Γεωργακόπουλος, Χρήστος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61623

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Georgakopoulos, Christos; Γεωργακόπουλος, Χρήστος. Μια μονοκεντρική, φάσης ΙΙ, τυφλοποιημένη ως προς τον αξιολογητή, τυχαιοποιημένη, ελεγχόμενη με ενεργό θεραπεία, παράλληλων ομάδων κλινική μελέτη για τη σύγκριση της τικαγκρελόρης έναντι της κλοπιδογρέλης στη μείωση της αορτικής σκληρίας και της ανάκλασης των κυμάτων πίεσης σε ασθενείς με στεφανιαία νόσο: η μελέτη “NOVELTY”. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/61623